Lucintel Forecasts the Global Head and Neck Cancer Diagnostic Market to reach 3.4 billion by 2030

According to a market report by Lucintel, the future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are the increasing prevalence of head and neck cancer, surfing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.
A more than 150-page report to understand trends, opportunity and forecast in head and neck cancer diagnostic market to 2030 by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the diagnosis category, imaging is expected to witness the highest growth over the forecast period.
Within the end use category, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also has the latest medical equipment and technology, which allows them to provide patients with the best possible care.
Download sample by clicking on head and neck cancer diagnostic market
In terms of regions, North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.
GE Healthcare, Philips, Siemens Healthineers, Merck, Eli Lilly are the major suppliers in the head and neck cancer diagnostic market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Contact Center Infrastructure (CCI) Software Market
Copper High Speed Connector Market
Electrical Transceiver Market
Glass Optical Elements Market
High-Performance Computing Cluster System Market

8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056

Lucintel is the one of the world's most reputed market research report company which provides market intelligence services that free up your market research and strategic planning resources (time, money and people) and allows you to focus on your core business. We assist you in the utilization of the best market intelligence for greater business gains and we do it faster, better and cheaper. Lucintel offers unmatched data and report quality as compared to the other market research report companies with highest customer satisfaction.

This release was published on openPR.